Archives

Bridge to Life, Ltd. announced investigational device exemption approval by the U.S. FDA for its VitaSmart™ Liver Machine Perfusion System and plans to enroll the first patient in its U.S. Bridge [...]

Bridge to Life, Ltd., a leading global supplier of organ preservation solutions and organ perfusion technologies, announced the first closing of a growth financing, totaling $56 million, led by [...]

Bridge to Life Chairman & CEO Stevan Schweighardt was interviewed in a feature piece for CEOCFO Magazine. He discusses the challenges of the transplant field and Bridge to Life's current and [...]

Bridge to Life, Ltd., a leading global supplier of organ preservation solutions and organ perfusion technologies, and Tevosol, Inc., a clinical stage medical device startup, today announced their [...]